by Canton & Company | Oct 29, 2019
You probably cringe when you see reports showing that Americans aren’t getting any healthier for the $3 trillion currently being spent on care. Reasons behind the weak return on investment include all the usual suspects: waste, poor patient engagement, administrative...
by Canton & Company | Oct 9, 2019
Analysts predict that Apple’s market opportunity in healthcare could reach as high as $313 billion in just a few years. Even the more conservative estimate of $15 billion is quite an eye-popper when you consider that Mayo Clinic’s 2018 revenue, for example, was $12...
by Canton & Company | Oct 8, 2019
Among all the healthcare stakeholders, payers capture the most data. Their giant claims processing machines gather up information from the entire provider community, not just a single silo. Their patient records also contain a universe of clinical info that is...
by Canton & Company | Jul 30, 2019
Massachusetts is among the more aggressive innovators when it comes to healthcare, and is one of just a dozen states implementing a Medicaid ACO model. We’ll be curious to see how providers integrate social determinants of health into their value-based plans —...
by Canton & Company | Jul 19, 2019
Necessity is the mother of invention, according to ancient Greek philosopher Plato. But we might argue that wants — not just needs or necessities — are giving rise to a wave of new inventions in healthcare’s opportunity era. In other words, consumers need good care,...
by Canton & Company | Apr 3, 2019
We’re keeping a close eye on the ingenious “Netflix model” two states are launching to pay for hepatitis C drugs. It certainly has some implications for how a Smart Health Market might approach rising drug spend. Earlier this year, Louisiana and Washington announced...
